REXULTI Drug General Use-results Survey (Excessive Motor Activity or Physically/Verbally Aggressive Behavior Due to Rapid Changes in Mood, Irritability, and/or Outbursts Associated With Dementia Due to Alzheimer's Disease)

ConditionAlzheimer Disease

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age15+

SponsorOtsuka Pharmaceutical Co., Ltd.

About this trial

The purpose of this study is to evaluate safety of REXULTI in patients under daily clinical settings. In addition, information on efficacy will be collected.

Eligibility criteria

Qualifiers

Patients diagnosed with Alzheimer's disease

Disqualifiers

None

Trial design

Treatments tested in this trial

Brexpiprazole (Rexulti)

Treatment groups

No treatment groups listed

Sponsors and collaborators

Otsuka Pharmaceutical Co., Ltd.

Lead sponsor

Source ClinicalTrials.gov